Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Biotech Gets Big Boost From Bills Enacted by Congress
Nov 22 1999
WASHINGTON, D.C. (Nov. 22, 1999) -- Included in the 2000 budget legislation passed by Congress are three measures that give a major boost to the biotechnology...
Scientific and Food Safety Issues Statement (The Food and Drug Administration Public Meeting)
Nov 18 1999
The Biotechnology Industry Organization (BIO) is pleased to be invited by the Food and Drug Administration (FDA) to participate on the Food Safety Panel for...
Public Information Issues Statement (The Food and Drug Administration Public Meeting)
Nov 18 1999
Thank you for inviting the Biotechnology Industry Organization (BIO) to provide a statement on the Food and Drug Administration's policy on information issues...
BIO Supports FDA Public Meetings On Biotech Foods
Nov 16 1999
WASHINGTON, D.C. (Nov. 16, 1999) -- The Biotechnology Industry Organization (BIO) fully concurs with the U.S. Food and Drug Administration's (FDA) initiative...
BIO Statement of FDA Food Hearing
Nov 16 1999
WASHINGTON, D.C. -- (Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement in advance of the Food and Drug...
BIO Responds to Labeling Bill
Nov 10 1999
(Michael J. Phillips, Ph.D, Executive Director for Food & Agriculture, issued the following statement in response to Congressman Kucinich's legislation...
Scientific Symposium To Show No Harm to Monarch Butterfly
Nov 2 1999
Nov. 2, 1999 (Chicago) -- Genetically improved corn poses negligible harm to the Monarch butterfly population, a panel of scientists is expected to conclude at...
BIO Brings Industry Leaders, Investors Together for æ2000 Reasons to Invest in Biotechnology'
Oct 22 1999
WASHINGTON, D.C. (Oct. 22, 1999) -- The BiotechnologyIndustry Organization will host its second annual CEO & Investor Conference, ô2000 Reasons to Invest...
BIO Responds to Anti-Biotech Advertisement in the NY Times
Oct 14 1999
October 14, 1999 Mr. Arthur O. Sulzberger, Jr.PublisherNew York Times229 West 43rd Street New York, NY 10036 Dear Mr. Sulzberger: On October 11, the New York...
Groups Call Attack on Safety Review of Biotech Foods ôBeyond Reasonö
Oct 7 1999
WASHINGTON, D.C. (October 6, 1999) -- The story ôBeyond Substantial Equivalenceö in Nature (10/7/99) is an unfounded attack on the concepts underpinning...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...